Director of Clinical Research
465 South Washington Street
North Attleboro, MA 02760
Regeneris is a full-time independent clinical research center located in southeastern Massachusetts. Our clinic is approximately 15 miles north of Providence, RI and 40 miles south of Boston in North Attleboro, MA. Regeneris is a multi-specialty clinical trial site that conducts Phase II-IV pharmaceutical and medical device clinical trials.
Our staff have collectively completed over 130 studies to date for a wide range of clients. We have a dedicated Recruiter, Regulatory Specialist, and four Clinical Research Coordinators with combined coordinating experience of over 23 years. Our Director has coordinating and managerial experience and focuses on business development, daily operations, and budget and contract negotiations. Our board certified Principal Investigator is on site five days per week.
We have an extensive database of patients and we utilize a broad array of multi media advertising campaigns as needed to extend our reach systematically throughout the community. These recruitment tactics provides us with access to an abundance of research study volunteers.
At Regeneris, our commitment to rapid enrollment while adhering to regulatory guidelines contribute to Tristan's high sponsor and patient retention rate. It is our mission to capture clean, accurate and complete data in an ethical manner and in accordance with the protocol, local and federal guidelines.
Our staff have completed clinical research trials in the following therapeutic areas:
Ryan Welter, M.D., Ph.D. is board certified in Family Medicine and has been conducting clinical research trials as a Principal Investigator since 2011.
It is Dr. Welter's mission to ensure that all research related activities are conducted in an ethical manner, adhering to Good Clinical Practice and data is gathered in a manner congruent with the protocol. He mandates that all documentation is captured and documented according to ALCOA standards.
Dr. Welter is on site five days per week and is easily accessible to research staff and patients and to sponsors and CRO's alike. He is on site actively involved in all aspects of clinical research, providing keen oversight and keeping his finger on the pulse of this ever changing industry.
Alex Wang is the Director of Clinical Research for Regeneris Medical. A recent masters graduate from Texas A&M, Alex has managed a multitude of clinical trials ranging in all areas of health and wellness. Alex directs the clinical research department with all current studies along with generating new studies for our clinical trial pipeline.
Our Coordinators have experience working with multiple electronic data capture systems as well as with Interactive web/ voice response systems. Some of those systems include Medidata, Rave, OCRDC, DataLabs, Cenduit, Inform, Clinphone, Phase Forward and DataTrak.
At Regeneris we are very familiar with and have developed solid working relationships with several central laboratories such as Quintiles, Covance, Lab Corp., MRL, MDS, ICON ,ACM, BRL, etc.
Additionally, we have successfully collaborated with various third party vendors to efficiently collect clean data for analysis. Time and again this has been demonstrated by timely and accurate completion of many projects with organizations such as eResearch technology, BioClinica, Synarc and Cardiocore who specialize in advanced imaging.
Invivodata, ePro, CRF Health, PHT Corp. and Diary Pro are all industry leaders that simplify the process of collecting patient reported outcomes by way of providing innovative electronic devices for first hand data collection and whom we at Regeneris have intimate working knowledge of.
We pride ourselves on completing all protocol required trainings in a timely manner to expedite study start up. Some of the training programs we are familiar with are ePharmaSolutions, Blue Sky, Clintara as well as countless sponsor specific training modules via electronic means, attendance of Investigator's meetings , hosting Site Initiation visits as well as participation in all refresher training sessions as required.
All Coordinators are required to maintain current GCP training and IATA certification.
Our Regulatory Specialist is well versed in all steps require to expedite study start up, often exceeding our expectation of a five day turn around on all documents and IRB submissions. Interim reporting and submissions as well as streamlining study close out procedures fall under the Regulatory Specialists scope of duties. Our Regulatory Specialist also assists with data entry and source document creation.
All Regeneris staff members assist with patient recruitment.
White alone 66.5%
Black or African American 13.4%
American Indian and Alaska Native 0.6%
Native Hawaiian and Other Pacific Islander 0.1%
Two or More Races 6.1%
Hispanic or Latino 19.7%
*Information sourced from www.quickfacts.census.gov
Our site utilizes central Institutional Review Boards for our trials which facilitates speedy document submissions, turn around and approvals. We've worked with many major Central IRB’s such as Schulman, Quorum, Copernicus Group, Central, IntegReview, Liberty and Aspire IRB and maintain access to electronic submission portals with many of the boards to expedite the submission process.